Correlation Between Idorsia and Molecular Partners

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Idorsia and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Idorsia and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Idorsia and Molecular Partners AG, you can compare the effects of market volatilities on Idorsia and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Idorsia with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Idorsia and Molecular Partners.

Diversification Opportunities for Idorsia and Molecular Partners

-0.42
  Correlation Coefficient

Very good diversification

The 3 months correlation between Idorsia and Molecular is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Idorsia and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Idorsia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Idorsia are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Idorsia i.e., Idorsia and Molecular Partners go up and down completely randomly.

Pair Corralation between Idorsia and Molecular Partners

Assuming the 90 days trading horizon Idorsia is expected to generate 3.45 times more return on investment than Molecular Partners. However, Idorsia is 3.45 times more volatile than Molecular Partners AG. It trades about 0.03 of its potential returns per unit of risk. Molecular Partners AG is currently generating about -0.08 per unit of risk. If you would invest  112.00  in Idorsia on October 9, 2024 and sell it today you would lose (22.00) from holding Idorsia or give up 19.64% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Idorsia  vs.  Molecular Partners AG

 Performance 
       Timeline  
Idorsia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Idorsia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Molecular Partners 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Insignificant
Over the last 90 days Molecular Partners AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly abnormal basic indicators, Molecular Partners showed solid returns over the last few months and may actually be approaching a breakup point.

Idorsia and Molecular Partners Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Idorsia and Molecular Partners

The main advantage of trading using opposite Idorsia and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Idorsia position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.
The idea behind Idorsia and Molecular Partners AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios